These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 8993844

  • 1. Transgenic rats: tools to study the function of the renin-angiotensin system.
    Bader M, Ganten D.
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S81-7. PubMed ID: 8993844
    [Abstract] [Full Text] [Related]

  • 2. Transgenic rats: tools to study the function of the renin-angiotensin system.
    Bader M, Ganten D.
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S81-7. PubMed ID: 21143278
    [Abstract] [Full Text] [Related]

  • 3. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y, Franco-Saenz R, Mulrow PJ.
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [Abstract] [Full Text] [Related]

  • 4. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
    Peters J, Münter K, Bader M, Hackenthal E, Mullins JJ, Ganten D.
    J Clin Invest; 1993 Mar; 91(3):742-7. PubMed ID: 8383701
    [Abstract] [Full Text] [Related]

  • 5. Adrenal renin expression and its role in ren-2 transgenic rats TGR(mREN2)27.
    Peters J, Ganten D.
    Horm Metab Res; 1998 Mar; 30(6-7):350-4. PubMed ID: 9694562
    [Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
    Gross V, Lippoldt A, Bohlender J, Ganten D, Ganten U, Luft FC.
    Exp Nephrol; 1996 Mar; 4 Suppl 1():20-6. PubMed ID: 9001893
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetics of primary hypertension.
    Ganten D, Schmidt S, Paul M.
    J Cardiovasc Pharmacol; 1994 Mar; 24 Suppl 3():S45-50. PubMed ID: 7700065
    [Abstract] [Full Text] [Related]

  • 13. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [Abstract] [Full Text] [Related]

  • 14. Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.
    Dechend R, Shagdarsuren E, Gratze P, Fiebeler A, Pilz B, Meiners S, Derer W, Feldman DL, Webb R, Muller DN.
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):81-4. PubMed ID: 17703434
    [Abstract] [Full Text] [Related]

  • 15. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K, Fujii K, Kansui Y, Iida M.
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
    Stasch JP, Knorr A, Hirth-Dietrich C, Krämer T, Hübsch W, Dressel J, Fey P, Beuck M, Sander E, Frobel K, Kazda S.
    Arzneimittelforschung; 1997 Sep; 47(9):1016-23. PubMed ID: 9342414
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.
    Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, Zimmermann F, Ruf P, Hilgenfeldt U, Ganten U.
    Proc Natl Acad Sci U S A; 1992 Aug 15; 89(16):7806-10. PubMed ID: 1502199
    [Abstract] [Full Text] [Related]

  • 20. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR.
    J Hum Hypertens; 2007 Oct 15; 21(10):770-9. PubMed ID: 17597800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.